Scientific Panel Discuss Challenges, Future Prospects for Developing HIV/AIDS Vaccine
October 10, 2003
A scientific panel on Wednesday in Washington, D.C., discussed the challenges, accomplishments and goals of the worldwide effort to develop an HIV/AIDS vaccine, the Inter Press Service reports. The panel was sponsored by the International AIDS Vaccine Initiative and focused on how to establish the vaccine manufacturing and distribution networks that will be necessary for the long-term fight against the disease. IAVI President and CEO Dr. Seth Berkley said that although there have been breakthroughs in global HIV/AIDS funding in 2003, with $22 billion being committed to battling the disease worldwide, there has not been "enough attention focused on a vaccine," adding, "We are never going to end the AIDS epidemic without a vaccine." Berkley said that IAVI's goal is to "move forward as soon as possible and build a global constituency" to develop a vaccine. Researchers have made a "tremendous amount of progress" toward developing a vaccine over the last five to seven years, with several vaccine candidates currently in different stages of clinical trials.
Current Efforts, Future Challenges
London's Guardian Examines Stigma, Other Obstacles to South African Companies' Antiretroviral Drug Programs
HIV/AIDS Is "Disease of Young People"; One Youth Infected Every 14 Seconds Worldwide, UNFPA Report Says
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.